CCR9 and COVID-19: Accordingly, CCL25 has been found to be elevated in the plasma of COVID-19 patients50, and a large-scale genome wide association study, involving patients with severe COVID-19, identified mutations in several chemokine receptors, including the CCL25 receptor CCR9 as a major risk factor for developing severe COVID-1951.